MedPath

The Effects of Whole Body Vibration in People With Chronic Stroke

Not Applicable
Completed
Conditions
Stroke
Registration Number
NCT03982251
Lead Sponsor
The Hong Kong Polytechnic University
Brief Summary

Whole body vibration (WBV) has been found to be useful in promoting bone health and muscle performance in older adults. To date, no study has examined the effects of different WBV frequencies on the properties of the muscle-bone unit in stroke patients. The overall aim of the proposed study is to compare the efficacy of different vibration frequencies on properties of the muscle function and bone turnover among people with chronic stroke.

It is hypothesized that the higher-vibration frequency protocol will lead to significantly better outcomes related to the bone turnover and muscle function.

Detailed Description

Whole body vibration (WBV) has been found to be useful in promoting bone health and muscle performance in older adults. To date, no study has examined the effects of different WBV frequencies on the properties of the muscle-bone unit in stroke patients. The overall aim of the proposed study is to compare the efficacy of different vibration frequencies on properties of the muscle function and bone turnover among people with chronic stroke.

It is hypothesized that the higher-vibration frequency protocol will lead to significantly better outcomes related to the bone turnover and muscle function in people with chronic stroke.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
80
Inclusion Criteria
  1. a diagnosis of stroke
  2. stroke onset >6 months
  3. >18 years of age
  4. able to walk for short distance independently with or without walking aid
  5. able to understand simple verbal commands
Exclusion Criteria
  1. neurological conditions other than stroke
  2. significant musculoskeletal conditions (e.g. amputations)
  3. metal implants in the lower extremity
  4. previous fracture of the lower extremity
  5. are currently taking bone resorption inhibitors or were taking the same before stroke.
  6. significant peripheral vascular disease
  7. vestibular disorders
  8. pregnancy
  9. Other serious illnesses that preclude the person from participating in the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
bone resorption markerpost-test (week8)

Serum level of aminoterminal crosslinked telopeptide

Secondary Outcome Measures
NameTimeMethod
Six Minute Walk Testpost-test (week8)

endurance Test

Spasticitypost-test (week8)

H-reflex on tibial nerve and modified ashworth scale

Gait velocitypost-test (week8)

10-meter walking test

Trial Locations

Locations (1)

The Hong Kong Polytechnic University

🇭🇰

Hongkong, Hong Kong

The Hong Kong Polytechnic University
🇭🇰Hongkong, Hong Kong

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.